[1] Zheng XF, Zhu F, Fang H, et al. Management of combined massive burn and blast injury: a 20-year experience. Burns, 2020; 46, 75−82. doi:  10.1016/j.burns.2018.11.010
[2] Lang TC, Zhao RL, Kim A, et al. A critical update of the assessment and acute management of patients with severe burns. Adv Wound Care (New Rochelle), 2019; 8, 607−33. doi:  10.1089/wound.2019.0963
[3] Huang CT, Lin HH, Ruan SY, et al. Efficacy and adverse events of high-frequency oscillatory ventilation in adult patients with acute respiratory distress syndrome: a meta-analysis. Crit Care, 2014; 18, R102. doi:  10.1186/cc13880
[4] Hughes KT, Beasley MB. Pulmonary manifestations of acute lung injury: more than just diffuse alveolar damage. Arch Pathol Lab Med, 2017; 141, 916−22. doi:  10.5858/arpa.2016-0342-RA
[5] Mowery NT, Terzian WTH, Nelson AC. Acute lung injury. Curr Probl Surg, 2020; 57, 100777. doi:  10.1016/j.cpsurg.2020.100777
[6] D'Alessio FR. Mouse models of acute lung injury and ARDS. In: Alper S, Janssen WJ. Lung Innate Immunity and Inflammation. Humana Press. 2018, 341-50.
[7] Cai WX, Shen K, Ji P, et al. The Notch pathway attenuates burn-induced acute lung injury in rats by repressing reactive oxygen species. Burns Trauma, 2022; 10, tkac008. doi:  10.1093/burnst/tkac008
[8] Song D, Zhao M, Feng LX, et al. Salidroside attenuates acute lung injury via inhibition of inflammatory cytokine production. Biomed Pharmacother, 2021; 142, 111949. doi:  10.1016/j.biopha.2021.111949
[9] Lei JL, Wei YL, Song PC, et al. Cordycepin inhibits LPS-induced acute lung injury by inhibiting inflammation and oxidative stress. Eur J Pharmacol, 2018; 818, 110−4. doi:  10.1016/j.ejphar.2017.10.029
[10] Xu YP, Zhu JQ, Feng B, et al. Immunosuppressive effect of mesenchymal stem cells on lung and gut CD8+ T cells in lipopolysaccharide-induced acute lung injury in mice. Cell Prolif, 2021; 54, e13028. doi:  10.1111/cpr.13028
[11] Xu F, Hu Y, Zhou JB, et al. Mesenchymal stem cells in acute lung injury: are they ready for translational medicine? J Cell Mol Med, 2013; 17, 927-35.
[12] Monsel A, Zhu YG, Gudapati V, et al. Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases. Expert Opin Biol Ther, 2016; 16, 859−71. doi:  10.1517/14712598.2016.1170804
[13] Guiot J, Struman I, Louis E, et al. Exosomal miRNAs in lung diseases: from biologic function to therapeutic targets. J Clin Med, 2019; 8, 1345. doi:  10.3390/jcm8091345
[14] Mizuta Y, Akahoshi T, Guo J, et al. Exosomes from adipose tissue-derived mesenchymal stem cells ameliorate histone-induced acute lung injury by activating the PI3K/Akt pathway in endothelial cells. Stem Cell Res Ther, 2020; 11, 508. doi:  10.1186/s13287-020-02015-9
[15] He CJ, Zheng S, Luo Y, et al. Exosome theranostics: biology and translational medicine. Theranostics, 2018; 8, 237−55. doi:  10.7150/thno.21945
[16] Yi XM, Wei XX, Lv HJ, et al. Corrigendum to "Exosomes derived from microRNA-30b-3p-overexpressing mesenchymal stem cells protect against lipopolysaccharide-induced acute lung injury by inhibiting SAA3" [Exp. Cell. Res. 383 (2019) 111, 454]. Exp Cell Res, 2020; 394, 112160. doi:  10.1016/j.yexcr.2020.112160
[17] Wei XX, Yi XM, Lv HJ, et al. Correction: MicroRNA-377-3p released by mesenchymal stem cell exosomes ameliorates lipopolysaccharide-induced acute lung injury by targeting RPTOR to induce autophagy. Cell Death Dis, 2020; 11, 746. doi:  10.1038/s41419-020-02976-y
[18] Xu Q, Huang GD, Duan GC, et al. MicroRNA-147b alleviates inflammation and apoptosis in acute lung injury via inhibition of p38 MAPK signaling pathway. Eur Rev Med Pharmacol Sci, 2021; 25, 1974−81.
[19] Zhang XL, An J, Deng YZ, et al. A novel miRNA-762/NFIX pathway modulates LPS-induced acute lung injury. Int Immunopharmacol, 2021; 100, 108066. doi:  10.1016/j.intimp.2021.108066
[20] Ahmad S, Zaki A, Manda K, et al. Vitamin-D ameliorates sepsis-induced acute lung injury via augmenting miR-149-5p and downregulating ER stress. J Nutr Biochem, 2022; 110, 109130. doi:  10.1016/j.jnutbio.2022.109130
[21] Liu JS, Du J, Cheng X, et al. Exosomal miR-451 from human umbilical cord mesenchymal stem cells attenuates burn-induced acute lung injury. J Chin Med Assoc, 2019; 82, 895−901. doi:  10.1097/JCMA.0000000000000189
[22] Huang XF, Xiu HQ, Zhang SF, et al. The role of macrophages in the pathogenesis of ALI/ARDS. Mediators Inflamm, 2018; 2018, 1264913.
[23] Deng JF, He ZP, Li XR, et al. Huangkui capsule attenuates lipopolysaccharide-induced acute lung injury and macrophage activation by suppressing inflammation and oxidative stress in mice. Evid Based Complement Alternat Med, 2021; 2021, 6626483.
[24] Liu JS, Xing FX, Fu QY, et al. hUC-MSCs exosomal miR-451 alleviated acute lung injury by modulating macrophage M2 polarization via regulating MIF-PI3K-AKT signaling pathway. Environ Toxicol, 2022; 37, 2819−31. doi:  10.1002/tox.23639
[25] Hu Y, Liu J, Wu YF, et al. mTOR and autophagy in regulation of acute lung injury: a review and perspective. Microbes Infect, 2014; 16, 727−34. doi:  10.1016/j.micinf.2014.07.005
[26] Fan EKY, Fan J. Regulation of alveolar macrophage death in acute lung inflammation. Respir Res, 2018; 19, 50. doi:  10.1186/s12931-018-0756-5
[27] Hu R, Chen ZF, Yan J, et al. Complement C5a exacerbates acute lung injury induced through autophagy-mediated alveolar macrophage apoptosis. Cell Death Dis, 2014; 5, e1330. doi:  10.1038/cddis.2014.274
[28] Qiu P, Liu Y, Chen KY, et al. Hydrogen-rich saline regulates the polarization and apoptosis of alveolar macrophages and attenuates lung injury via suppression of autophagy in septic rats. Ann Transl Med, 2021; 9, 974. doi:  10.21037/atm-21-2489
[29] Song L, Su M, Wang SY, et al. MiR-451 is decreased in hypertrophic cardiomyopathy and regulates autophagy by targeting TSC1. J Cell Mol Med, 2014; 18, 2266−74. doi:  10.1111/jcmm.12380
[30] Zhang HB, Cicchetti G, Onda H, et al. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest, 2003; 112, 1223−33. doi:  10.1172/JCI200317222
[31] TargetScan Human. https: //www. targetscan. org/. [2023-11-8].
[32] Liu JY, Liu JL, Wang H, et al. Protective effect of celastrol for burn-induced acute lung injury in rats. Int J Clin Exp Pathol, 2019; 12, 576−83.
[33] Xiao MJ, Zou XF, Li B, et al. Simulated aeromedical evacuation exacerbates burn induced lung injury: targeting mitochondrial DNA for reversal. Mil Med Res, 2021; 8, 30.
[34] Luo JH, Zhan JH, You HY, et al. MicroRNA-146a/Toll-like receptor 4 signaling protects against severe burn-induced remote acute lung injury in rats via anti-inflammation. Mol Med Rep, 2018; 17, 8377−84.
[35] Hu XH, Liu LY, Wang Y, et al. Human umbilical cord-derived mesenchymal stem cells alleviate acute lung injury caused by severe burn via secreting TSG-6 and inhibiting inflammatory response. Stem Cells Int, 2022; 2022, 8661689.
[36] Liu LY, Song HF, Duan HJ, et al. TSG-6 secreted by human umbilical cord-MSCs attenuates severe burn-induced excessive inflammation via inhibiting activations of P38 and JNK signaling. Sci Rep, 2016; 6, 30121. doi:  10.1038/srep30121
[37] Wei XX, Yi XM, Lv HJ, et al. MicroRNA-377-3p released by mesenchymal stem cell exosomes ameliorates lipopolysaccharide-induced acute lung injury by targeting RPTOR to induce autophagy. Cell Death Dis, 2020; 11, 657. doi:  10.1038/s41419-020-02857-4
[38] Zheng YF, Liu JY, Chen P, et al. Retraction notice to "Exosomal miR-22-3p from human umbilical cord blood-derived mesenchymal stem cells protects against lipopolysaccharid-induced acute lung injury" [Life Sci. 269 (2021) 119004]. Life Sci, 2023; 322, 121601. doi:  10.1016/j.lfs.2023.121601
[39] Xu XL, Li H, Gong Y, et al. Hydrogen sulfide ameliorated lipopolysaccharide-induced acute lung injury by inhibiting autophagy through PI3K/Akt/mTOR pathway in mice. Biochem Biophys Res Commun, 2018; 507, 514−8. doi:  10.1016/j.bbrc.2018.11.081
[40] Song L, Zhou FL, Cheng LJ, et al. MicroRNA-34a suppresses autophagy in alveolar type II epithelial cells in acute lung injury by inhibiting FoxO3 expression. Inflammation, 2017; 40, 927−36. doi:  10.1007/s10753-017-0537-1
[41] Slavin SA, Leonard A, Grose V, et al. Autophagy inhibitor 3-methyladenine protects against endothelial cell barrier dysfunction in acute lung injury. Am J Physiol Lung Cell Mol Physiol, 2018; 314, L388−96. doi:  10.1152/ajplung.00555.2016
[42] Liu C, Xiao K, Xie LX. Progress in preclinical studies of macrophage autophagy in the regulation of ALI/ARDS. Front Immunol, 2022; 13, 922702. doi:  10.3389/fimmu.2022.922702
[43] He N, Tan HY, Deng XY, et al. MiR-223-3p-loaded exosomes from bronchoalveolar lavage fluid promote alveolar macrophage autophagy and reduce acute lung injury by inhibiting the expression of STK39. Hum Cell, 2022; 35, 1736−51. doi:  10.1007/s13577-022-00762-w
[44] Ying Y, Sun CB, Zhang SQ, et al. Induction of autophagy via the TLR4/NF-κB signaling pathway by astragaloside Ⅳ contributes to the amelioration of inflammation in RAW264.7 cells. Biomed Pharmacother, 2021; 137, 111271. doi:  10.1016/j.biopha.2021.111271
[45] Gump JM, Thorburn A. Autophagy and apoptosis: what is the connection? Trends Cell Biol, 2011; 21, 387-92.
[46] Wang LQ, Cai J, Zhao X, et al. Palmitoylation prevents sustained inflammation by limiting NLRP3 inflammasome activation through chaperone-mediated autophagy. Mol Cell, 2023; 83, 281-97. e10.
[47] Cao Y, Chen JH, Ren GF, et al. Punicalagin prevents inflammation in LPS-induced RAW264.7 macrophages by inhibiting FoxO3a/autophagy signaling pathway. Nutrients, 2019; 11, 2794. doi:  10.3390/nu11112794
[48] Shaw GC, Cope JJ, Li LT, et al. Mitoferrin is essential for erythroid iron assimilation. Nature, 2006; 440, 96−100. doi:  10.1038/nature04512
[49] Fokam D, Hoskin D. Instrumental role for reactive oxygen species in the inflammatory response. Front Biosci (Landmark Ed), 2020; 25, 1110−19. doi:  10.2741/4848
[50] Guo YX, Liu YR, Zhao SH, et al. Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages. Nat Commun, 2021; 12, 7094. doi:  10.1038/s41467-021-27428-9
[51] Kong LM, Deng J, Zhou X, et al. Sitagliptin activates the p62-Keap1-Nrf2 signalling pathway to alleviate oxidative stress and excessive autophagy in severe acute pancreatitis-related acute lung injury. Cell Death Dis, 2021; 12, 928. doi:  10.1038/s41419-021-04227-0
[52] Zhang HT, Wang L, Li CY, et al. Exosome-induced regulation in inflammatory bowel disease. Front Immunol, 2019; 10, 1464. doi:  10.3389/fimmu.2019.01464
[53] Li XH, Wei YL, Li SM, et al. Zanubrutinib ameliorates lipopolysaccharide-induced acute lung injury via regulating macrophage polarization. Int Immunopharmacol, 2022; 111, 109138. doi:  10.1016/j.intimp.2022.109138
[54] Luan PX, Chen XM, Zhang XF, et al. Role of miR-451 in mediating cadmium induced head kidney injury in common carp via targeting cacna1ab through autophagy pathways. Aquat Toxicol, 2022; 248, 106201. doi:  10.1016/j.aquatox.2022.106201
[55] Liu F, Bu ZY, Zhao F, et al. Increased T-helper 17 cell differentiation mediated by exosome-mediated microRNA-451 redistribution in gastric cancer infiltrated T cells. Cancer Sci, 2018; 109, 65−73. doi:  10.1111/cas.13429
[56] Nan Y, Guo HB, Guo LY, et al. MiRNA-451 inhibits glioma cell proliferation and invasion through the mTOR/HIF-1α/VEGF signaling pathway by targeting CAB39. Hum Gene Ther Clin Dev, 2018; 29, 156−66. doi:  10.1089/humc.2018.133
[57] Cui JY, Wang J, Shen YY, et al. Suppression of HELLS by miR-451a represses mTOR pathway to hinder aggressiveness of SCLC. Genes Genomics, 2021; 43, 105−14. doi:  10.1007/s13258-020-01028-1
[58] Liu ZR, Song Y, Wan LH, et al. Over-expression of miR-451a can enhance the sensitivity of breast cancer cells to tamoxifen by regulating 14-3-3ζ, estrogen receptor α, and autophagy. Life Sci, 2016; 149, 104−13. doi:  10.1016/j.lfs.2016.02.059
[59] Li CY, Chen YP, Chen XP, et al. Downregulation of MicroRNA-193b-3p promotes autophagy and cell survival by targeting TSC1/mTOR signaling in NSC-34 cells. Front Mol Neurosci, 2017; 10, 160. doi:  10.3389/fnmol.2017.00160
[60] Wang YQ, Zhang XY, Tang W, et al. miR-130a upregulates mTOR pathway by targeting TSC1 and is transactivated by NF-κB in high-grade serous ovarian carcinoma. Cell Death Differ, 2017; 24, 2089−100. doi:  10.1038/cdd.2017.129